Chicago Equity Partners LLC bought a new stake in shares of PetMed Express, Inc. (NASDAQ:PETS) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 8,180 shares of the company’s stock, valued at approximately $271,000.
Several other large investors have also bought and sold shares of PETS. Teachers Advisors LLC grew its position in shares of PetMed Express by 1.8% during the 1st quarter. Teachers Advisors LLC now owns 61,884 shares of the company’s stock valued at $1,246,000 after acquiring an additional 1,097 shares during the period. Thrivent Financial For Lutherans grew its position in shares of PetMed Express by 4.1% during the 1st quarter. Thrivent Financial For Lutherans now owns 11,530 shares of the company’s stock valued at $232,000 after acquiring an additional 450 shares during the period. Vanguard Group Inc. grew its position in shares of PetMed Express by 4.3% during the 1st quarter. Vanguard Group Inc. now owns 1,075,251 shares of the company’s stock valued at $21,656,000 after acquiring an additional 44,560 shares during the period. Geode Capital Management LLC grew its position in shares of PetMed Express by 4.2% during the 1st quarter. Geode Capital Management LLC now owns 164,993 shares of the company’s stock valued at $3,322,000 after acquiring an additional 6,582 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in shares of PetMed Express by 24.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 794,669 shares of the company’s stock valued at $16,005,000 after acquiring an additional 153,709 shares during the period. Hedge funds and other institutional investors own 87.13% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Chicago Equity Partners LLC Takes Position in PetMed Express, Inc. (PETS)” was originally published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://transcriptdaily.com/2017/11/19/chicago-equity-partners-llc-takes-position-in-petmed-express-inc-pets.html.
Shares of PetMed Express, Inc. (NASDAQ PETS) opened at $38.67 on Friday. PetMed Express, Inc. has a twelve month low of $19.21 and a twelve month high of $50.90. The stock has a market capitalization of $796.76, a PE ratio of 25.95, a P/E/G ratio of 2.32 and a beta of 1.09.
PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.13. PetMed Express had a return on equity of 31.46% and a net margin of 11.58%. The company had revenue of $66.70 million for the quarter, compared to analysts’ expectations of $63.41 million. During the same period in the previous year, the firm posted $0.24 EPS. PetMed Express’s revenue was up 9.7% compared to the same quarter last year. research analysts expect that PetMed Express, Inc. will post 1.67 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 17th. Investors of record on Monday, November 6th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.07%. The ex-dividend date was Friday, November 3rd. PetMed Express’s payout ratio is 53.69%.
A number of equities research analysts have recently commented on the company. Noble Financial restated a “hold” rating on shares of PetMed Express in a research report on Wednesday, July 26th. Northcoast Research upgraded PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 price objective on the stock in a report on Monday, July 24th. Credit Suisse Group reiterated an “underperform” rating and issued a $19.00 price objective on shares of PetMed Express in a report on Monday, October 2nd. Zacks Investment Research cut PetMed Express from a “strong-buy” rating to a “hold” rating in a report on Monday, September 25th. Finally, ValuEngine cut PetMed Express from a “buy” rating to a “hold” rating in a report on Monday, October 2nd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $42.00.
In other news, Director Ronald J. Korn sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $35.57, for a total transaction of $35,570.00. Following the transaction, the director now directly owns 73,833 shares in the company, valued at approximately $2,626,239.81. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 4.00% of the company’s stock.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.